Home » Topics » BioWorld Science

BioWorld Science
RSS

T Cell Sciences awarded SBIR grant for atherosclerosis vaccine

Jan. 23, 1998

Viracept approved for marketing in E.U. member countries

Jan. 23, 1998

HMR's new ketolides extensively discussed at conference this week

Jan. 23, 1998

Clinical results reported for Servier's MDR-reversing agent S-9788

Jan. 23, 1998

Abbott presents in vitro and in vivo efficacy data on tricyclic ketolides

Jan. 23, 1998

Lexacalcitol: a vitamin D analogue with increased potency

Jan. 23, 1998

Efficacy and safety of oral contraception demonstrated in men

Jan. 23, 1998

Ontogen describes novel MDR modulators

Jan. 23, 1998

New class of macrolides developed at Abbott

Jan. 23, 1998

Merck & Co. describes FPTase inhibitors with improved pharmacokinetics

Jan. 23, 1998

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...